An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancer

por Thiery-Vuillemin, A., Fizazi, K., Sartor, O., Oudard, S., Bury, D., Thangavelu, K., Ozatilgan, A., Poole, E.M., Eisenberger, M., de Bono, J.
Publicado 2021

Plasma inflammatory cytokines and survival of pancreatic cancer patients

por Babic, A., Schnure, N., Neupane, N. P., Zaman, M. M., Rifai, N., Welch, M. W., Brais, L. K., Rubinson, D. A., Morales-Oyarvide, V., Yuan, C., Zhang, S., Poole, E. M., Wolpin, B. M., Kulke, M. H., Barbie, D. A., Wong, K., Fuchs, C. S., Ng, K.
Publicado 2018